• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Health Care Supplies

Uroplasty Inc

+ Add to Watchlist


2.8000 USD 0.0900 3.11%

As of 20:10:00 ET on 08/20/2014.

Snapshot for Uroplasty Inc (UPI)

Open: 2.9787 Day's Range: 2.8000 - 2.9900 Volume: 20,581
Previous Close: 2.8900 52wk Range: 2.3200 - 5.4000 1-Yr Rtn: -4.11%

Stock Chart for UPI

No chart data available.
  • UPI:US 2.8000
  • 1D
  • 1M
  • 1Y
Interactive UPI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for UPI

Current P/E Ratio (ttm) -
Estimated P/E(03/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.2700
Est. EPS (USD) (03/2015) -0.2650
Est. PEG Ratio -
Market Cap (M USD) 61.73
Shares Outstanding (M) 22.05
30 Day Average Volume 44,551
Price/Book (mrq) 5.4231
Price/Sale (ttm) 2.3793
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/24/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for UPI

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for UPI

Uroplasty, Inc. designs, develops, manufactures, and markets medical products primarily for the treatment of voiding dysfunctions. The Company's principal product is Urgent PC Neuromodulation System which is a system that delivers percutaneous tibial nerve stimulation (PTNS) for the office-based treatment of overactive bladder. Uroplasty also offers Macroplastique, a bulking agent.

Kill C Robert "Rob"President/CEOBrett A ReynoldsSenior VP/CFO/Secretary
Darin HammersSenior VP:Global Sales & MktgDavid B PerryVP:Marketing
More Company Profile & Key Executives for UPI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil